Interested in becoming an ACAAI member? Learn more about the benefits of membership and find your place in the College.



Promoting Innovation and Diversity
November 4-8, 2021 - New Orleans, LA

Submission Deadline: Monday, July 12, 2021 - 5:00 PM CDT


The College invites you to submit an abstract for the 2021 Annual Scientific Meeting, November 4 - 8, New Orleans. The theme of the meeting is: Promoting Innovation and Diversity

Scientific Research Abstract Submissions

  • Abstracts may be submitted by fellows, members and non-members of the College.
  • ACAAI only accepts original abstracts.
  • Abstracts reporting results of quality improvement work will be accepted. See "Organization of Abstract Body" below for submission guidance.
  • ACAAI will not be accepting late-breaking abstracts.
  • Accepted abstracts will be published in a supplement of the Annals of Allergy, Asthma & Immunology.
  • The highest scoring, non-commercial, research abstracts will be considered for presentation during the Oral Abstract sessions (CME).
  • All other accepted abstracts will be presented during the Annual Meeting as electronic posters on Friday, Saturday and Sunday.
  • Industry research abstracts will be eligible for consideration of "Distinguished Industry Oral Abstracts" (see details below).
  • FITs should apply for the Clemons von Pirquet Award when submitting an abstract - 3 winners will be selected.

The deadline for submission of Scientific Research Abstracts is July 12, 2021 (5:00 pm CDT).

All accepted Abstracts will be published in print and online as they appear within the ACAAI System as of the deadline date. No changes can be made to the online or print publication after the close of the submission period.

Distinguished Industry Oral Abstract Presentations. The College will select the top research abstracts from industry to be designated as Distinguished Industry Oral Abstracts. These will be presented during two concurrent Saturday, November 6th sessions from 4:30-5:30 pm. This special event will take place, unopposed and with refreshments, just prior to the all-popular FIT Bowl.


Submission Information for Authors. Abstracts must be submitted electronically via the online form, and they must be complete, including the author listing. A limit of 10 authors per abstract may be included. ACAAI will not accept any abstracts or abstract changes after the submission deadline. Abstract changes include: changes to title or body, changes to presenting authors, author additions, revised author names, and/or revised author listing. The deadline for Research Abstract submission and receipt of all author disclosures is 5:00 PM (CDT) on July 12, 2021. This deadline applies to ALL scientific research abstracts.

NOTE: All correspondence regarding the abstract submission will be sent to the submitter at the email address provided at time of submission. It is the responsibility of the submitter to ensure that all information is correct and approved by the participating authors.

Authorship. The College follows the ICMJE quidelines. The ICMJE recommends that authorship be based on the following 4 criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved

Commercial Bias. All abstracts must be devoid of commercial bias. Trade names should not be used in referencing drugs, devices or instrumentation. Any medications or other substances referred to in the presentation material should be identified by their generic name or description. Trade name violations/commercial bias will result in below average scores or rejection. Failure to disclose financial relationships with ACCME-defined *commercial interests will prohibit an author/presenter from participating in oral and poster sessions.

Employees of pharmaceutical or medical device companies or other ACCME-defined *commercial interests are prohibited from participating as an author or presenter of an oral abstract chosen for presentation during a CME Session; however, they may participate as an author or presenter for an electronic poster session, or an abstract chosen for oral presentation during a non-CME Distinguished Industry Oral Abstracts session.

*An ACCME-defined commercial interest is, “any entity producing, marketing, reselling or distributing healthcare goods or services used on, or consumed by, patients.”

All authors must complete the online Disclosure of Financial Relationships by July 12, 2021 at 5:00 PM Central for Research Abstracts. Failure to comply with this requirement will result in the author being removed from the abstract.

Abstract Presentations. ACAAI only accepts original abstracts. Abstracts previously accepted and/or published by other organizations should not be submitted. If an abstract submitted to ACAAI Annual Meeting is accepted for programming and/or publication by another organization prior to its acceptance by ACAAI, it must be withdrawn from consideration for the ACAAI Annual Meeting.

We will not make the assumption that the submitting author is the presenting author. If you are the submitting author and the presenting author, you must list your name in the author listing and select the role of "Presenting Author." abstract. If submitting more than one abstract, you may identify a co-author as the presenter for other abstracts. An individual can only be the presenting author on one abstract.

As the submitting author, you are the main contact person for the abstract, and as such, it is your responsibility to make sure the other authors are informed of an communications from ACAAI regarding the abstract (including requests from the Abstract Review Subcommittee for additional information, disposition and placement decision, missing disclosures, etc). If you are unwilling or unable to function in this capacity, please designate an alternate contact person.

It is the responsibility of the submitting author to ensure accuracy of content, spelling and author information, including author listing order. Abstracts are directly exported from the submission database for publication.

Please review your submission carefully to make sure that all appropriate data and all authors are listed and in the correct order. Absolutely no changes to the body copy, data, authors or author order listing will be accepted after the July 12, 2021 5:00 pm (CDT) deadline.

Submission Fee. There is a $60 non-refundable fee for each abstract submission. Payment does not guarantee acceptance. Payment must be made by credit card (Visa, MasterCard or American Express). Purchase orders and checks will not be accepted.

Abstract Withdrawal. A written request must be submitted to education@acaai.org by July 12, 2021. Any abstract withdrawn after that date cannot be assured removal from the 2021 ACAAI Annual Scientific Meeting Program Guide or the November supplement to ACAAI's official Journal, the Annals of Allergy, Asthma and Immunology.

Required Information Needed for Each Author. You must list your authors in the order in which they should appear in the abstract. If you are the presenting author, your name needs to be listed first in the author block

First Name, Middle Initial and Last Name

Company/Institution Name

City, State and Country (where employed)

Author Email

A "Presenting Author" must be identified by the July 12, 2021 deadline date for the abstract to be considered.

All authors listed on your abstract will receive an email with a link for completing their disclosure. Please make sure they respond; all authors are REQUIRED to disclose and it will be your responsibility as the Submitter and/or Presenting Author to follow-up with the authors to make sure the disclosures have been submitted.

Any author who has not completed the online disclosure by the July 12, 2021 deadline, will be removed from the abstract.


Organization of Abstract Body

Abstract Length. There is a limit of 15 words for the title and 250 words for the body of your abstract submission.

Each abstract should be formatted as shown below (including the words "Introduction", "Methods", "Results" and "Conclusion" within your abstract submission:


Submitting a Quality Improvement abstract? Click here for alternate formatting guidance.


Introduction: A brief introduction indicating the reason for the study

Methods: A description of the methods used to evaluate the study (do not include laboratory techniques)

Results: Specific data necessary to evaluate the abstract (Statements such as “data will be discussed at the presentation” are grounds for refusal of the abstract)
Conclusion: A brief conclusion indicating the significance of the results in terms of what was originally designed. The results should occupy 1/2 to 2/3 of the abstract. DO NOT mention the institution where the work was performed in the body or title of the abstract.

Be sure to use the words “Introduction, Methods, Results, Conclusion” in the body of your abstract to indicate the start of each new section. The abstract title and author information should not be included in the body of the abstract.

Best Results. Best results are achieved copying and pasting directly from a Word document. Please make sure that you use the "Insert Symbols" feature in Word for any mathematical, Latin or scientific expressions. If you are entering the copy directly onto the Abstract Form, you must use the “Symbols” icon to ensure your results are displayed accurately. Always verify that your information is correct prior to submitting by selecting "Print Preview."

Title Guidelines. Capitalize the first letter of each word of the title. Do not use formatting tags in the title. The title will be formatted automatically by the system at the time of print production. Abbreviations must not be used in the title. Check to ensure that you have not exceeded the character count limit.

Editorial Policies for Authors (ICMJE Guidance)
Reproduced Materials - When previously published figures or tables are used, the author must obtain written permission from the copyright holder (usually the publisher) to reproduce the material in print and online. An appropriate credit line should be included in the figure legend or table footnote, and full publication information should be cited in the reference list. Letters of permission must accompany the manuscript at the time of submission.

Use of Figures. You may add one figure to your abstract, however, it is recommended that results be shown in narrative form, since figure formats may be compromised in publication. The figure must be submitted as a jpg file and cannot exceed 500kb.

Abstract Acceptance. If the abstract is accepted for presentation at the 2021 ACAAI Annual Meeting, the submitting author will be notified via email in late-August. Only the submitting author will be notified of the abstract disposition. Please make sure that your contact information is accurate. The notification will include: 1) placement decision; 2) date and time of session; and 3) format of presentation (oral or electronic poster). Abstracts scheduled for presentation will be grouped by topic, numbered and listed in the program and published in the November Annals of Allergy, Asthma and Immunology abstract supplement. The decision of the ACAAI Abstract Review Subcommittee regarding acceptance and presentation of abstracts is final.

Meeting Registration. All authors who will be attending the Annual Meeting must register online for the meeting and pay any applicable registration fees. The meeting registration site will open in early August

Electronic Posters. For your convenience, all accepted posters for the 2021 ACAAI Annual Meeting will be displayed electronically. In addition to display in the ePoster location during the times that the Exhibit Hall is open, they will be available online 24/7. There will be monitors available during any of the non-display times and you should feel free to invite your colleagues to come view and discuss your ePoster during one of those times. Technical staff will be available to assist throughout the meeting. Complete details regarding the electronic posters will be sent to the submitting author of accepted abstracts at the end of August.


Back to Top